1,124 reports of this reaction
3.5% of all MECLIZINE HCL 25MG reports
#2 most reported adverse reaction
NAUSEA is the #2 most commonly reported adverse reaction for MECLIZINE HCL 25MG, manufactured by Advanced Rx LLC. There are 1,124 FDA adverse event reports linking MECLIZINE HCL 25MG to NAUSEA. This represents approximately 3.5% of all 32,433 adverse event reports for this drug.
Patients taking MECLIZINE HCL 25MG who experience nausea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
NAUSEA is moderately reported among MECLIZINE HCL 25MG users, representing a notable but not dominant share of adverse events.
In addition to nausea, the following adverse reactions have been reported for MECLIZINE HCL 25MG:
The following drugs have also been linked to nausea in FDA adverse event reports:
NAUSEA has been reported as an adverse event in 1,124 FDA reports for MECLIZINE HCL 25MG. This does not prove causation, but indicates an association observed in post-market surveillance data.
NAUSEA accounts for approximately 3.5% of all adverse event reports for MECLIZINE HCL 25MG, making it one of the most commonly reported side effect.
If you experience nausea while taking MECLIZINE HCL 25MG, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.